The global instrument calibrator market is expected to grow from US$ 1,277.57 million in 2021 to US$ 1,854.03 million by 2028; it is estimated to grow at a CAGR of 5.5% during 2021–2028.
Calibration is the process of comparing unknown values obtained for devices under test (DUT) to a known value reference standard.In pharmaceutical manufacturing, strict safety requirements and regulations must be maintained, and manufacturing processes are consistent and reliable.
This ensures product purity and the best possible end-product quality, both of which are important for patient safety.As a result, several pressure and temperature measurements, such as local indicators (gauges), transmitters, and switches, are common place in these operations.
Many of these tests are performed in harsh circumstances, such as in autoclaves, centrifuge machines, and sonicators.For instance, in the chemical industry, it’s used to cure coatings, vulcanize rubber, and perform hydrothermal synthesis, as well as in medical applications to perform sterilization.
The timely calibration of instruments, followed by systematic and appropriate paperwork, is a critical for ensuring that the pharmaceutical products are manufactured as per the current good manufacturing practices (cGMPs). In case of any technical issues in instruments, the calibration data can help understand when, when, and how an error occurred. As a result, pharmaceutical regulatory authorities keep a check on the type of data collected and the interval between calibrations.
Pharmaceutical companies need a complete calibration solution that meets with industry regulations while increasing efficiency and improving data integrity and quality standards.Temperature, pressure, and electrical calibrators are required for the frequent calibration of various pharmaceutical equipment, such as medical testing instruments, weather stations, thermistors, and furnaces.
Thus, the pharmaceuticals industry is contributing to the instrument calibrators market growth. The instrument calibrator market is segmented in terms of product type, modularity, industry vertical, and geography.Based on product type, the instrument calibrator market is segmented into temperature calibrator, pressure calibrator, electrical calibrator, and multifunction process calibrator.
In 2020, the pressure calibrator segment led the instrument calibrator market, accounting for the largest share in the market.In terms of modularity, the instrument calibrator market can be segmented into benchtop and portable.
In 2020, the portable segment accounted for the largest market share.Similarly, based on industry vertical, the instrument calibrator market can be segmented into automotive, aerospace and defense, electronics, food & beverage, pharmaceutical, oil & gas, and other industries.
In 2020, the other industries segment accounted for the largest market share. Geographically, the market is broadly segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South America (SAM). In 2020, APAC accounted for the significant share in the global market.
The COVID-19 pandemic had a negative impact on the global instrument calibrator market in the year 2020.Since the outbreak of COVID-19, all manufacturing processes across the world have been temporarily closed to combat the spread of COVID-19 and comply with the social distancing norms laid down by local and federal government bodies.
Therefore, the closure of manufacturing units is resulting into logistic issues. However, as the manufacturing processes resumed from the 3rd quarter of 2020, and the demand for instrument calibrator started to recover, manufacturers were able to stabilize the overall revenue and cashflow.
The overall instrument calibrator market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.
The process also serves the purpose of obtaining an overview and forecast for the instrument calibrator market with respect to all the segments.It also provides the overview and forecast for the market based on all the segmentation provided with respect to five major regions—North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Also, primary interviews were conducted with industry participants and commentators to validate data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the instrument calibrator market.
The key companies operating in the instrument calibrator market include AMETEK Inc., Baker Hughes Company, Extech Instruments, Fluke Corporation, Yokogawa Electric Corporation, WIKA Alexander Wiegand SE & Co. KG, Additel, Beamex Oy Ab, Calmet, and Spectris.
Our reports have been used by over 10K customers, including:
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to grow from $0.96 billion in 2020 to $1.1 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The growth is...
The global process analytical instrumentation market is expected to witness a CAGR of 7.56% over the forecast period (2021-2026). In the market analyzed, the recent COVID-19 outbreak resulted in high demand. During the COVID-19 outbreak, the need for accelerated research has grown substantially, and the public expects exceptional progress...
The market for dust control systems and suppression chemicals is valued at USD 12,350 million in 2020 and is expected to grow at a CAGR of more than 4% during the forecast period. Restrictions by governments in various countries due to the spread of COVID-19 have placed difficulties on mining companies operating in affected countries....
The global pharmaceutical contract development and manufacturing market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in...
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
The global Micropump market is expected to reach US$ 5,172.86 million in 2028 from as estimated value of US$ 1,553.01 million in 2021. The market is likely to grow with a CAGR of 18.8% from 2021-2028. The growth of the market is due to increasing demand for micropumps in medical device industry, and improved accuracy compared to traditional...
The global Raman spectroscopy market is projected to reach USD 861 million by 2026 from an estimated USD 602 million in 2021, at a CAGR of 7.4% from 2021 to 2026. The Rise in adoption of Raman spectroscopy in clinical applications and advancement in utilization of Raman spectroscopic techniques for catalysts and catalytic reactions are among...
The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, an increasing number of clinical trials, and the...
Pharmaceutical R&D Expenditure
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.